BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27306318)

  • 41. XRCC1 Arg399Gln gene polymorphism and hepatocellular carcinoma risk in the Italian population.
    Santonocito C; Scapaticci M; Nedovic B; Annicchiarico EB; Guarino D; Leoncini E; Boccia S; Gasbarrini A; Capoluongo E
    Int J Biol Markers; 2017 May; 32(2):e190-e194. PubMed ID: 28058700
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer.
    Brewster AM; Jorgensen TJ; Ruczinski I; Huang HY; Hoffman S; Thuita L; Newschaffer C; Lunn RM; Bell D; Helzlsouer KJ
    Breast Cancer Res Treat; 2006 Jan; 95(1):73-80. PubMed ID: 16319991
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Contribution of DNA Repair Xeroderma Pigmentosum Group D Genotypes to Colorectal Cancer Risk in Taiwan.
    Chang WS; Yueh TC; Tsai CW; Ji HX; Wu CN; Wang SC; Lai YL; Hsu SW; Hsieh MH; Hsiao CL; Hung YW; Shih TC; Bau DT
    Anticancer Res; 2016 Apr; 36(4):1657-63. PubMed ID: 27069143
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An updated meta-analysis between the association of XRCC1 Arg399Gln polymorphism and hepatocellular carcinoma risk.
    Zhang XL; Lu Y; Yang S; Peng QL; Wang J; Xie L; Deng Y; He Y; Li TJ; Qin X; Li S
    Asian Pac J Cancer Prev; 2014; 15(7):3273-8. PubMed ID: 24815482
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients.
    Chang-Claude J; Popanda O; Tan XL; Kropp S; Helmbold I; von Fournier D; Haase W; Sautter-Bihl ML; Wenz F; Schmezer P; Ambrosone CB
    Clin Cancer Res; 2005 Jul; 11(13):4802-9. PubMed ID: 16000577
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk.
    De Ruyck K; Szaumkessel M; De Rudder I; Dehoorne A; Vral A; Claes K; Velghe A; Van Meerbeeck J; Thierens H
    Mutat Res; 2007 Jul; 631(2):101-10. PubMed ID: 17531525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polymorphisms of the DNA repair genes XPD and XRCC1 and the risk of age-related macular degeneration.
    Görgün E; Güven M; Unal M; Batar B; Güven GS; Yenerel M; Tatlipinar S; Seven M; Yüksel A
    Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4732-7. PubMed ID: 20375340
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Study on the DNA repair gene XRCC1 and XRCC3 polymorphism in prediction and prognosis of hepatocellular carcinoma risk.
    Han X; Xing Q; Li Y; Sun J; Ji H; Huazheng P; Jun L
    Hepatogastroenterology; 2012 Oct; 59(119):2285-9. PubMed ID: 22456434
    [TBL] [Abstract][Full Text] [Related]  

  • 49. XRCC1 Arg399Gln gene polymorphism and hepatocellular carcinoma risk in the Chinese Han population: a meta-analysis.
    Duan WH; Zhu ZY; Liu JG; Dong MS; Chen JZ; Liu QD; Xie Y; Sun TY; Gao ZF; Zhou NX
    Asian Pac J Cancer Prev; 2012; 13(8):3601-4. PubMed ID: 23098440
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DNA repair gene XRCC3 Thr241Met polymorphism and hepatocellular carcinoma risk.
    Duan C; Zhang W; Lu J; Wu H; Liu M; Zhu W
    Tumour Biol; 2013 Oct; 34(5):2827-34. PubMed ID: 23824570
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A meta-analysis of xeroderma pigmentosum gene D Ls751Gln polymorphism and susceptibility to hepatocellular carcinoma.
    Wang Y; Zhao Y; Zhang A; Ma J; Wang Z; Zhang X
    Int J Clin Exp Pathol; 2015; 8(10):12949-54. PubMed ID: 26722489
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DNA repair gene XRCC3 T241M polymorphism and susceptibility to hepatocellular carcinoma in a Chinese population: a meta-analysis.
    Ji RB; Qian YS; Hu AR; Hu YR
    Genet Mol Res; 2015 Dec; 14(4):15988-96. PubMed ID: 26662391
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DNA Repair Genes XRCC1, XRCC3, XPD, and OGG1 Polymorphisms among the Central Region Population of Saudi Arabia.
    Alanazi M; Pathan AA; Ajaj SA; Khan W; Shaik JP; Al Tassan N; Parine NR
    Biol Res; 2013; 46(2):161-7. PubMed ID: 23959014
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Association of the xeroderma pigmentosum group D DNA repair gene with hepatocellular carcinoma].
    Zhang JJ; Ma JZ
    Zhonghua Gan Zang Bing Za Zhi; 2012 Sep; 20(9):683-7. PubMed ID: 23207233
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The investigation of DNA repair polymorphisms with histopathological characteristics and hormone receptors in a group of Brazilian women with breast cancer.
    Dufloth RM; Arruda A; Heinrich JK; Schmitt F; Zeferino LC
    Genet Mol Res; 2008 Jul; 7(3):574-82. PubMed ID: 18752184
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Single nucleotide polymorphisms of DNA repair genes XRCC1 and XPD and its molecular mapping in Indian oral cancer.
    Ramachandran S; Ramadas K; Hariharan R; Rejnish Kumar R; Radhakrishna Pillai M
    Oral Oncol; 2006 Apr; 42(4):350-62. PubMed ID: 16324877
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic polymorphisms of the DNA repair gene and risk of nasopharyngeal carcinoma.
    Yang ZH; Du B; Wei YS; Zhang JH; Zhou B; Liang WB; Jia J; Zhang BL; Zhang L
    DNA Cell Biol; 2007 Jul; 26(7):491-6. PubMed ID: 17630853
    [TBL] [Abstract][Full Text] [Related]  

  • 58. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis.
    Liu F; Li B; Wei Y; Yan L; Wen T; Zhao J; Xu M
    Liver Int; 2011 Jul; 31(6):802-9. PubMed ID: 21645210
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Susceptibility of XRCC3, XPD, and XPG genetic variants to cervical carcinoma.
    He X; Ye F; Zhang J; Cheng Q; Shen J; Chen H
    Pathobiology; 2008; 75(6):356-63. PubMed ID: 19096231
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polymorphisms in DNA repair genes XRCC1, XRCC3 and XPD, and colorectal cancer risk: a case-control study in an Indian population.
    Wang J; Zhao Y; Jiang J; Gajalakshmi V; Kuriki K; Nakamura S; Akasaka S; Ishikawa H; Suzuki S; Nagaya T; Tokudome S
    J Cancer Res Clin Oncol; 2010 Oct; 136(10):1517-25. PubMed ID: 20229274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.